CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totaling 207 shares, a decline of 62.5% from the June 15th total of 552 shares. Based on an average daily volume of 4,625 shares, the days-to-cover ratio is presently 0.0 days.
CSPC Pharmaceutical Group Stock Performance
Shares of OTCMKTS:CSPCY opened at C$4.17 on Monday. The firm’s 50 day moving average price is C$3.79 and its 200-day moving average price is C$4.41. CSPC Pharmaceutical Group has a twelve month low of C$3.26 and a twelve month high of C$5.83.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Featured Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
